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Although many aspects of hepatic function have been known and studied for a
number of years, little is known about the immunological function of the liver.
Chronic liver disease is often accompanied by an absolute increase in serum gamma
globulin concentration. All the major immunoglobulin classes may be involved, and
the elevated globulin is due to increased synthesis rather than decreased metabolism
(1). In this review mechanisms are examined whereby the normal liver may modify
the immune response to antigens, and the damaged liver may lead to increased im-
munoglobulin synthesis.
EXPERIMENTAL STUDIES
In 1946, Chase (2) showed that guinea pigs could be rendered tolerant to intra-
muscular immunization with dinitrochlorobenzene (DNCB) by prior feeding with
hapten. This phenomenon, subsequently named the Chase-Sulzberger effect, has
been confirmed using other haptens, and tolerance may even be induced by a single
feeding prior to intramuscular immunization (3). The possible role of the liver was
first suggested by Cantor and Dumont (4). They examined the antibody response to
intramuscular DNCB in dogs, and found that this was substantially reduced in ani-
mals fed with the hapten prior to immunization, and that this reduction was
abolished ifthe animals were subjected to portacaval shunting before the start ofthe
experiment. Interpretation ofsuch feeding experiments is limited in that the rate and
quantity of antigen absorption cannot be assessed. We (5) have studied the effect of
the liver on the immune response in the rat by injecting sheep red blood cells directly
into the portal vein and comparing the antibody response obtained with an equiva-
lent injection via the inferior vena cava in control animals. Whereas the antibody
response to a single dose of antigen was similar by either route, repeated portal
venous injections of antigen produced a significantly lower antibody response than
did repeated inferior vena cava injections (Table 1). The dose of antigen
administered was critical; too little antigen failed to evoke a sufficient antibody
response by either route for a difference to be detectable, while an excessive amount
ofantigen produced a large antibody response by either routeofadministration.
Radio-labeling of the antigen with 5"Cr showed that in the nonimmunized animal
the percentage uptake by the liver after a single injection was the same regardless of
route of administration. By contrast, although repeated portal vein immunization
resulted in the same percentage uptake by the liver, repeated inferior vena cava im-
munization resulted in decreased uptake by the liver.
Delayed hypersensitivity was also examined in these animals by measuring the in-
crease in ear thickness after intraauricular injection of sheep red cells. Rats im-
munized repeatedly via the inferior vena cava showed evidence of delayed
hypersensitivity, while the animals immunized via the portal vein did not. In the
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same animal model, damage to the liver by carbon tetrachloride led to an increased
antibody response to sheep red cells, a fall in the percentage oflabeled antigen taken
up by the liver, and abolition of the difference in antibody response to repeated im-
munization between the two routes (6). An enhanced antibody response to sheep red
cells after reduction in the amount of antigen taken up by the liver has also been
produced by Souhami (7) by blockading the reticuloendothelial cells ofthe liver with
colloidal carbon, although in this study the effect ofimmunization via the portal vein
was not examined.
These findings are consistent with the theory that the intact liver is able to modify
the immune response to exogenous antigens by sequestering them and rendering
then nonimmunogenic and even, under certain circumstances, inducing tolerance to
these antigens. Such a hypothesis presupposes that the hepatic macrophages-the
Kupffer cells-behavedifferently from other macrophages in that antigens taken up
by them lose their immunogenicity. Franzl (8) has shown that, whereas subcellular
fractions of spleen containing antigen retain significant antigenicity for several days
after the uptake of antigen, comparable liver fractions lost all detectable antigenic
properties within 12 hr.
As well as being able to sequester antigens, the liver may also influence the im-
mune response by removing antigen/antibody complexes from the circulation.
Thomas and colleagues (9) have demonstrated this in the experimental animal using
12mibovine serum albumin, and in addition they have shown thatdamage to the liver
significantly reduces theability to take up such complexes.
CLINICAL OBSERVATIONS
These animal studies may be relevant to observations in human liver disease. The
elevated immunoglobulin levels found in chronic liver disease are due to increased
synthesis and thus reflect increased antibody production. Since this may occur in the
absence of activinse nsitdamage (10) the increased antibody production may reflect
an abnormal response to exogenous antigens.
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SEQUESTRATION OF ANTIGENS BY THE LIVER
Antigens from the intestinal microbial flora comprise the largest source of
exogenous antigen (11), and the liver is uniquely situated in that it receives a large
proportion of the systemic blood flow in addition to the entire portal venous system.
Thus, antigens absorbed from the gastrointestinal tract must pass through the liver
before they reach the antibody-producing cells in the spleen and elsewhere in the re-
ticuloendothelial system. If the liver is damaged and the functional capacity of the
Kupffer cells impaired, it is logical to expect that the antigens in the portal venous
system would fail to be sequestered by the liver. As a result, increased amounts of
antigen would become available to the antibody-producing cells in the spleen and
other parts of the reticuloendothelial system, with consequent increased antibody
production. Studies (12) of antibody titers to E. coli, and Bacteroides in liver disease
support this. Antibody titers to both of these gastrointestinal tract organisms are
significantly elevated in patients with chronic liver disease, in contrast to nongas-
trointestinal tract organisms such as Haemophilus influenzae B. Serial studies in
acute hepatitis have shown that antibody titers to E. coli rise significantly some
weeks after the onset of hepatitis, falling gradually to normal several months after
the resolution of the liver disease. The transient loss of function of the reticuloendo-
thelial cells of the liver may be due either to the frank destruction of the Kupffer
cells accompanying the hepatitis or to a saturation of the phagocytic properties of
these cells by the breakdown products ofthe damaged tissue.
In addition to loss of functional capacity of the liver cells, a second mechanism is
likely to contribute to the bypassing of the liver. Portal hypertension with the es-
tablishment of a collateral circulation is a frequent finding in many cases of chronic
liver disease. Under these circumstances, antigen absorbed into the portal blood
would reach the systemic circulation after bypassing the liver by way of the
collateral blood vessels. This mechanism could play a significant role even in the
presence ofnormal liver cell function. Rats with intact livers subjected to portacaval
shunting have been shown to develop hyperglobulinemia and increased antibody
titers to E. coli(13). Indirect evidence in support of this hypothesis is provided by the
retrospective observations of Bj0rneboe and colleagues (14) that patients with
portacaval anastomoses have higher antibody titers to E. coli than do those without
a shunt.
We2 have measured E. coli antibody titers in sera obtained from patients with cir-
rhosis and portal hypertension both before and at varying intervals after
prophylactic portacaval anastomosis. A comparable group of patients who did not
undergo portacaval anastomosis served as controls. Measurements were made
using the method described previously (12). The results of the study are shown in
Table 2. It will be seen that the mean E. coli antibody titer in the sera of 21 patients
examined 26 mo after portacaval anastomosis is no higher than the presurgery sera.
The control group sera showed titers of similar magnitude. This would suggest that
the creation of a portacaval shunt has no effect on the E. coli antibody titer. It
should be remembered, however, that patients with cirrhosis and portal hyperten-
sion already have severe liver damage and also a preexisting collateral circulation,
thus providing two factors to encourage bypassing of the liver by antigen. Thus, the
surgical creation of a portacaval shunt in these patients is unlikely to affect this
2Study performed in collaboration with Dr. H. 0. Conn, Veterans Administration Hospital, West
Haven, CN.
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TABLE 2
Effect of Portacaval Anastomosis on E. coli Antibody Titers
in Patients with Cirrhosis of the Liver
Cirrhosis Cirrhosis
without with
portacaval portacaval
anastomosis anastomosis
No. of patients studied 18 21
Mean interval between 1st and 2nd serum (mo) 24 (1-97) 26 (2-71)
Mean E. coli antibody titer (log2) in 1st sample 5.3 5.0
Mean E. coli antibody titer (log2) in 2nd sample 5.4 4.9
No. of sera showing elevated E. coli antibody titer in 1st samplea 6/18 7/21
aE. coli antibody titer >1/32 (log25) taken as being elevated (12).
situation significantly. The observation that one third of the patients have elevated
E. coli antibody titers in thefirst sample studied lends support to this explanation.
A major assumption used in interpreting these data is that bacterial antigens are
absorbed from the gastrointestinal tract into the portal blood, rather than into the
lymphatic system. Absorption via the latter route would bypass the liver under any
circumstances, and so damage to the liver would have little or no effect. Warshaw et
al. (15) have been able to study the uptake oflabeled macromolecules in cannulated
lymphatics and branches of the portal vein from isolated loops of bowel. These
studies have shown that significant quantities of bovine serum albumin are
transported directly to the lymphatic system, and this may be why antibody titers to
albumin are notincreased in patients with liverdisease (12).
Grossly elevated antibody titers to measles, rubella, and cytomegalic inclusion
virus have been found in patients with chronic activehepatitis (16, 17). This increase
in antibody titer appears to be highly selective, since antibodies to Herpes simplex,
varicella-zoster, para-influenza 1, Coxsackie B1 and B5 and Mycoplasma pneu-
moniae are all within normal limits. Antibody titers to all these viruses werenormal
in other types ofchronic liver disease, except the cytomegalovirus, to which elevated
titers have been found in patients with alcoholic cirrhosis and primary biliary cir-
rhosis. Increased antibody titers have also been reported to some viruses in acute
viral hepatitis. Alwen (18) has shown an increase in neutralizing antibody titers to
adenovirus type 5 in acute hepatitis A infection, while Baals and colleagues (19)
found increased titers to cytomegalovirus in patients with hepatitis, particularly
those associated with the Hepatitis Bs antigen. Table 3 summarizes the elevated an-
tibody titers to microbial and dietary protein antibodies hitherto reported in liver
disease.
Why should such striking elevations in viral antibody titers occur in chronic active
hepatitis? The explanation here must be different from that postulated for bacterial
antibodies, since none of these viruses is usually associated with the gastrointestinal
tract. Increases in antibody titers to measles and rubella have been reported in sys-
temic lupus erythematosis (22), and it has been suggested that this may be part of a
phenomenon of nonspecific hyperreactivity, or that it might be associated with the
finding of virus-like particles in renal biopsy material in lupus nephritis (23). The
magnitude of the increase in antibody titers in chronic active hepatitis is much
greater than that found in the connective tissue disorders. Normal antibody titers
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TABLE 3
Elevated Microbial and Dietary Protein
Antibody Titers Found in Liver Diseasea
Chronic
Acute active
Antigen hepatitis Cirrhosis hepatitis
Salmonella (14,20) 0 - +
E. coli(12,14) + + +
Bacteroides (12) + + +
Measles (16) - - +
Rubella (16) - - +
Cytomegalovirus (16,19) + + +
Adenovirus (18) + 0 0
Toxoplasma gondii (21) 0 + 0
Gluten fraction III (12) + +
o&Lactalbumin (12) - +
Colon antigen (12) - - +
a+ Significantly increased titers;
- No increase in antibody titers; 0 Not examined.
to cytomegalovirus have been reported in SLE, and measles, rubella, and
cytomegalovirus do not appear to show any common antigenic determinants. A
possible explanation for these findings may lie in the fact that infection with these
three viruses is associated with a viremia, after which a low level ofcirculating anti-
body persists for life, possibly a response to repeated release of small quantities of
viral antigen (16). Since the Kupffer cells are known to be capable of sequestering
viral antigens (24), the intact liver could play a significant role in regulating the
amount of circulating antigen. In chronic active hepatitis the macrophage activity
might be so depressed that the ability to sequester these antigens is lost and theviral
antigens would then become available to antibody-producing cells elsewhere with a
consequent increase in antibody production. Alternatively, the viral antigens (but
not necessarily the intact viruses themselves) may be sequestered in the liver
macrophages and be rendered temporarily nonimmunogenic, only to be released
after the liver damage which occurs in chronic activehepatitis. In contrast, infection
with the other viruses studied is rarely accompanied by viremia, and although
viruses such as Herpes simplex and Varicella-zoster may persist for many years, an-
tibodies are likely to be produced in the lymph close to the virus. In such circum-
stances, viral antigenemia is unlikely to occur and hence damage to the liver would
not affect the mechanism ofantibody production.
OTHER MECHANISMS FOR ENHANCED ANTIBODY PRODUCTION
Although this discussion has related the increased antibody response induced by
exogenous antigens in liver disease to a failure of the sequestering properties of the
Kupifer cells, other mechanisms may also contribute.
Adjuvant Effect ofLiver Tissue
The breakdown products ofliver cell necrosis, such as nucleic acids, can be shown
experimentally to produce an adjuvant effect (25). Such a phenomenon might ex-
plain some of the increased antibody titers which have been observed in active liver
necrosis, but it is unlikely to account for the persistent hyperglobulinemia often
found in established inactivehepatic cirrhosis.
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Autoantigens
There is considerable evidence (26) to suggest that antigens are produced as a
direct result of liver damage, and that these may provide a stimulus to the produc-
tion ofantibodies, although the extent oftheir contribution to antibody formation in
human liver disease is uncertain. Autoantibodies are commonly found in the serum
of patients with both acute and chronic liver disease, but they are neither organ-
specific nor species-specific. They may occur in the absence of overt liver disease,
and the development of clinical liver disease has been observed in such patients
without any alteration in the autoantibody titers (16). Patients with chronic active
hepatitis commonly have strongly positive antinuclear and antismooth muslce anti-
bodies and we have found (17) a very significant correlation between the elevated
measles and rubella antibody titers and the strongly positive autoantibodies. It is
possible that the autoantibodies may represent markers for potential immunological
disturbance such that damage to the liver in these people may lead to a loss of the
functional ability ofthe Kupffer cells to sequester these antigens.
Decreased ImmunologicalSurveillance due to T-Cell Deficiency
with Normal orEnhancedB-Cell Function
Cooperation between T and B lymphocytes is a crucial factor in the production
of antibodies and there is evidence (27) to suggest that under certain circumstances
in which T-cell function is altered, the normal regulatory mechanisms may be over-
come with the production ofan autoimmune response. Depressed cell-mediated im-
munity is known to occur in many forms ofliver disease (28), and the increased anti-
body production may reflect a compensatory B-cell overaction to a wide variety of
antigenic stimuli not necessarily related to the pathogenesis (10). This interrelation-
ship between T- and B-cell function has been demonstrated for a number ofantigens
(29) in animal models, but ifit is applicable to clinical liver disease, the selectivity of
the exaggerated B-cell responsehas still to beexplained.
ROLE OF ENDOTOXIN
Endotoxin is largely derived from the gram-negative bacilli in thegastrointestinal
tract, and after absorption makes a major contribution to the high levels found in
the liver. Animal studies have shown that under conditions ofexperimental cirrhosis
the handling ofendotoxin by the liver is impaired (30), and Heyman and Beeson (31)
have shown that patients with cirrhosis of the liver are unusually sensitive to en-
dotoxin. The recent finding (32) that endotoxin is a potent B-cell mitogen is of
considerable interest, since the effect of increased amounts of endotoxin reaching
the appropriate organs ofthe reticuloendothelial system would be to stimulate anti-
body production. Clearly this may be an important factor in the etiology of the in-
creased antibody titers found in chronic liver disease, but much more knowledge is
required before this can be accepted. It does not provide any explanation for the se-
lective increase in antibody titer which has been described. Furthermore, although
endotoxin has been shown to be an effective stimulant, in vitro its immunological
role in man has yet to be established. Since, in man, using the most sensitive assay
yet devised, endotoxin can be detected only in the presence of severe gram-negative
shock, it is hard to assess its clinical importance. The failure to detect endotoxin in
the blood does not rule out an important role, since the critical factor would be the
presence ofendotoxin in the antibody-producing sites, but much morework needs to
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be done on the kinetics and metabolism ofendotoxin in relation to the reticuloendo-
thelial system before its role can be adequately assessed.
CONCLUSION
The evidence reviewed suggests that the liver may play a significant role in the se-
questering of exogenous antigen and can thus modify the immune response.
Hitherto, most studies ofthe immune response to antigens have considered the reti-
culoendothelial system as a whole, but in the light of the significant antigen-seques-
tering properties of the liver, the time may be opportune to examine individual
components of the immune system. One can imagine how the intact liver may
protect the organism against possible harmful immunological effects of exogenous
antigens, but whether damage to this function of the liver plays any role in the
potentiation of chronic liver disease merits further investigation. Immune complex
information is dependent upon the ratio of the antigen to antibody, and so distur-
bance in the sequestering properties of the liver may influence this. Once formed,
complexes are largely cleared by the liver (9), but in situations ofliver damage this
may be impaired with consequent deposition in other organs such as occurs in
arthritis, polyarteritis, and glomerulonephritis associated with hepatitis Bs antigen
(33). Likewise, the possibility that Kupffer cell function may be impaired in other
conditions of excessive antibody formation such as collagen disease deserves to be
studied. In summary, yet another chapter in the long list offunctions attributable to
the liver appears to beunfolding.
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